Piotr Ozieranski1, Lawrence King2. Show Affiliations » 1. Bath. 2. Cambridge.
Abstract
Mesh: See more » Antiviral Agents/economicsAntiviral Agents/therapeutic useCarbamates/economicsCarbamates/therapeutic useDrug ApprovalDrug CombinationsEnglandHepatitis C/drug therapyHepatitis C/economicsHeterocyclic Compounds, 4 or More Rings/economicsHeterocyclic Compounds, 4 or More Rings/therapeutic useHumansSofosbuvir/economicsSofosbuvir/therapeutic useState Medicine/economicsWales
Substances: See more » Antiviral AgentsCarbamatesDrug CombinationsHeterocyclic Compounds, 4 or More Ringssofosbuvir-velpatasvir drug combinationSofosbuvir
Year: 2016 PMID: 27908876 DOI: 10.1136/bmj.i6499
Source DB: PubMed Journal: BMJ ISSN: 0959-8138